BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1986386)

  • 1. Pancreatic tumor pathogenesis reflects the causative genetic lesion.
    Sandgren EP; Quaife CJ; Paulovich AG; Palmiter RD; Brinster RL
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):93-7. PubMed ID: 1986386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.
    Quaife CJ; Pinkert CA; Ornitz DM; Palmiter RD; Brinster RL
    Cell; 1987 Mar; 48(6):1023-34. PubMed ID: 3470144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.
    Zhu L; Shi G; Schmidt CM; Hruban RH; Konieczny SF
    Am J Pathol; 2007 Jul; 171(1):263-73. PubMed ID: 17591971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of KRAS Mutation in Acinar and Langerhans Islet Cells of Patients With Pancreatic Ductal Adenocarcinoma.
    Wang Z; Zhang C; Nagee K; Mohammadi A; Monteiro C
    Pancreas; 2016 Mar; 45(3):337-41. PubMed ID: 26474433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
    Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
    Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
    Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
    BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the basic helix-loop-helix transcription factor p48 in the differentiation phenotype of exocrine pancreas cancer cells.
    Adell T; Gómez-Cuadrado A; Skoudy A; Pettengill OS; Longnecker DS; Real FX
    Cell Growth Differ; 2000 Mar; 11(3):137-47. PubMed ID: 10768861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed exocrine-endocrine tumors of the pancreas.
    Klöppel G
    Semin Diagn Pathol; 2000 May; 17(2):104-8. PubMed ID: 10839610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
    Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
    Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.
    Sawai Y; Kodama Y; Shimizu T; Ota Y; Maruno T; Eso Y; Kurita A; Shiokawa M; Tsuji Y; Uza N; Matsumoto Y; Masui T; Uemoto S; Marusawa H; Chiba T
    Cancer Res; 2015 Aug; 75(16):3292-301. PubMed ID: 26113087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
    Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L
    Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The link between exocrine pancreatic cancer and the endocrine pancreas.
    Pour PM; Schmied B
    Int J Pancreatol; 1999 Apr; 25(2):77-87. PubMed ID: 10360219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pancreatic acinar neoplasms : Comparative molecular characterization].
    Bergmann F
    Pathologe; 2016 Nov; 37(Suppl 2):191-195. PubMed ID: 27807633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.